UDG Healthcare unit Sharp Clinical Services has signed a central pharmacy partnership deal with European central pharmacy Hubertus, Germany.
Direct-to-Patient Trials: How IRT Plays an Important Role in Bellerophon's Direct-to-Patient Trials
It also developed a holistic patient support programme with its sister company Ashfield, a healthcare advisory firm.
The central pharmacy partnership deal will support Sharp’s direct-to-patient logistics service for its clinical trial customers in Europe and the surrounding nations.
Sharp Clinical Service Business Development global head Sascha Sonnenberg said: “I’m excited to see how we have successfully worked together with our partners and colleagues to establish a comprehensive solution to the benefit of our clients and patients participating in clinical trials.
“This is not just a temporary option during the Covid-19 situation, but will experience an increasing demand in a post-pandemic era.”
Sharp has also joined forces with the Patient Solutions business unit of Ashfield.
The service, according to Sharp, will provide clinical educator-led ministering in injection training, infusions, as well as blood pressure monitoring to patients in their home.
Sharp said that this service can either be delivered via in-person visits in Europe or remotely in both the US and Europe for clinical study sponsors.
Sascha added: “The breadth and depth of this solution is a unique offering to sponsors in the clinical services market. We can now provide a holistic solution delivering drugs directly to trial participants, as well as supporting them throughout their participation.”
Sharp Clinical is a global provider of clinical trial services, including analytical, formulation development, clinical manufacturing and packaging, as well as storage and distribution.
Related Companies
